ES8201150A1 - Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos - Google Patents

Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos

Info

Publication number
ES8201150A1
ES8201150A1 ES499508A ES499508A ES8201150A1 ES 8201150 A1 ES8201150 A1 ES 8201150A1 ES 499508 A ES499508 A ES 499508A ES 499508 A ES499508 A ES 499508A ES 8201150 A1 ES8201150 A1 ES 8201150A1
Authority
ES
Spain
Prior art keywords
preparation
sulfamoyl
therapy
compounds
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES499508A
Other languages
English (en)
Other versions
ES499508A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES499508A0 publication Critical patent/ES499508A0/es
Publication of ES8201150A1 publication Critical patent/ES8201150A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE ACIDOS 5-SULFAMOILORTANILICOS DE FOMULA (I), EN QUE R ES ALCOHILO, ALQUENILO, CICLOALCOHILO O CICLOALCOHILALCOHILO, Y AR FENILO, TIENILO O FUNILO. SE BASA EN LA SAPONIFICACION DE UN ESTER DE FORMULA (II), SIENDO Z UN RADICAL AROMATIVO, EN UN MEDIO ACUOSO, CON UNA BASE INORGANICA COMO LEGA DE SOSA O DE POTASA. SE NEUTRALIZA LA SOLUCION DE SAPONIFICACION, A TEMPERATURA AMBIENTE, CON UN ACIDO MINERAL U ORGANICO. EL PRODUCTO CRISTALIZADO, EN FORMA DE SALES SODICAS O POTASICAS, SE RECOGE POR PRECIPITACION. SE LAVA CON UN DISOLVENTE ORGANICO Y SE RECRISTALIZA EN ALCOHOLES ACUOSOS. SE USAN EN PREPARADOS FARMACEUTICOS COMO AGENTES SALIDIURETICOS.
ES499508A 1980-02-22 1981-02-17 Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos Expired ES8201150A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803006686 DE3006686A1 (de) 1980-02-22 1980-02-22 5-sulfamoyl-orthanilsaeuren, verfahren zu ihrer herstellung und ihre verwendung als heilmittel

Publications (2)

Publication Number Publication Date
ES499508A0 ES499508A0 (es) 1981-12-01
ES8201150A1 true ES8201150A1 (es) 1981-12-01

Family

ID=6095322

Family Applications (3)

Application Number Title Priority Date Filing Date
ES499510A Granted ES499510A0 (es) 1980-02-22 1981-02-17 Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos
ES499508A Expired ES8201150A1 (es) 1980-02-22 1981-02-17 Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos
ES499509A Granted ES499509A0 (es) 1980-02-22 1981-02-17 Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES499510A Granted ES499510A0 (es) 1980-02-22 1981-02-17 Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES499509A Granted ES499509A0 (es) 1980-02-22 1981-02-17 Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos

Country Status (14)

Country Link
US (1) US4339446A (es)
EP (1) EP0034746B1 (es)
JP (1) JPS56142257A (es)
AR (1) AR230622A1 (es)
AT (1) ATE5883T1 (es)
AU (1) AU536892B2 (es)
CA (1) CA1155449A (es)
DE (2) DE3006686A1 (es)
DK (1) DK77881A (es)
ES (3) ES499510A0 (es)
FI (1) FI810510L (es)
HU (1) HU187300B (es)
IL (1) IL62176A0 (es)
ZA (1) ZA811144B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0506792A (pt) * 2004-02-20 2007-05-22 Aventis Pharma Inc derivados de furosemida como moduladores de hm74 e seu uso no tratamento de inflamação

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875150A (en) * 1969-04-29 1975-04-01 Leo Pharm Prod Ltd New sulfamyl-anthranilic acids
US3812104A (en) * 1971-06-25 1974-05-21 Ciba Geigy Corp 5-arylsulfamyl-anthranilic acids
GB1364366A (en) * 1971-07-20 1974-08-21 Tera Middle East Pharmaceutica Derivatives of 4-chloro-5-sulphamoyl-anthranilic acid their preparation and pahamaceutical compositions comprising them
DE2142758A1 (de) * 1971-08-26 1973-03-01 Ciba Geigy Ag Aromatische sulfamoylverbindungen
DE2232457A1 (de) * 1972-07-01 1974-01-10 Boehringer Mannheim Gmbh Neue 3-alkyl-4-sulfamoylanilinderivate

Also Published As

Publication number Publication date
ES499508A0 (es) 1981-12-01
IL62176A0 (en) 1981-03-31
EP0034746B1 (de) 1984-01-18
ES8201152A1 (es) 1981-12-01
ES499510A0 (es) 1981-12-01
EP0034746A1 (de) 1981-09-02
DE3161905D1 (en) 1984-02-23
ES8201151A1 (es) 1981-12-01
AU6750781A (en) 1982-09-16
AR230622A1 (es) 1984-05-31
JPS56142257A (en) 1981-11-06
FI810510A7 (fi) 1981-08-23
ZA811144B (en) 1982-03-31
ATE5883T1 (de) 1984-02-15
DE3006686A1 (de) 1981-08-27
ES499509A0 (es) 1981-12-01
FI810510L (fi) 1981-08-23
CA1155449A (en) 1983-10-18
US4339446A (en) 1982-07-13
AU536892B2 (en) 1984-05-31
HU187300B (en) 1985-12-28
DK77881A (da) 1981-08-23

Similar Documents

Publication Publication Date Title
FI98460B (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
NO921002L (no) Nye estere av tienylkarboksylsyrer og aminoalkoholer, deres kvartaeriseringsprodukter, og fremstilling og anvendelseav forbindelsene
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
NO151325C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme glukosederivater
SE8406138L (sv) Nya retinoider
DK199789D0 (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
ES8301878A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
IT7921788A0 (it) Composizione farmaceutica contenente un derivato di acido para-amminobenzoico come ingrediente attivo.
ES8201150A1 (es) Procedimiento para la preparacion de acidos 5-sulfamoilorta-nilicos
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
HUT54113A (en) Process for producing butenecarboxylic acid derivatives and pharmaceutical compositions comprising such compounds
DE69000719D1 (de) Hautreinigungsmittel.
DK384489A (da) 6-fluor-3,5-dihydroxycarboxylsyrer og deres derivater, deres fremstilling og anvendelser
AR003093A1 (es) Nuevos derivados de imidazol-n-bencildioxol, su procedimiento de preparacion, su aplicacion a titulo de medicamentos, composicionesfarmaceuticas y nueva utilizacion.
FR2381781A1 (fr) Derives de la guanine et medicament contenant ces substances
SE8503225L (sv) Diacyloxi-1,8-acyl-10-antroner, sett for deras framstellning och deras anvendning som lekemedel for djur och menniska samt for kosmetika
ATE15044T1 (de) Bis-ester von alkandiolen, pharmazeutische zusammensetzungen und zwischenprodukte.
BR9200917A (pt) Composto aro'matico,processo para sua producao,composicao e processo para controlar pragas de insetos bem como uso do dito composto
FR2382901A1 (es)
JPS5455596A (en) Cordycepin derivative and its preparation
ES2060051T3 (es) Acidos s-alquiltiopropionicos y derivados.
ES8606868A1 (es) Procedimiento para la obtencion de derivados de la 1,4-dihi-dro-piridina
ES476405A1 (es) Un metodo para la preparacion de 2-metiltio-6-fluoro-9-(1- metil-4-piperilideno)-tioxanteno

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001